In this episode, we dive into the realities of dealing with portfolio drawdowns as dividend growth investors. From personal examples to strategies for averaging down, price anchoring, and knowing when to hold or sell, we share how we manage the emotions that come with falling share prices.
We also cover the latest news and dividend hikes, including:
Novo Nordisk – promising results from its new oral weight-loss drug
London Stock Exchange Group – stepping into blockchain with Microsoft
Intel & Nvidia – surprising partnerships in the chip industry
Texas Instruments, Microsoft, W.P. Carey, and Philip Morris – dividend hike updates
Plus, we review Bradley’s dividend portfolio and answer listener questions on hedging against USD, quick dividend stock screeners, reinvestment strategies, tax-efficient accounts, and more.
🎙️ Tickers discussed: NVO, LSEG, INTC, NVDA, TXN, MSFT, WPC, PM, CNQ, LGEN, EOG, O, ARES, HASI, PLD, BAM, DTE, AD, VICI, PAYX, UNH, NEE, LVMH, UL
